Thursday’s big stock stories: What’s likely to move the market in the next trading session

Investing News

A trader works on the floor of the New York Stock Exchange.
NYSE

Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last look at today. Sign up for free to receive it directly in your inbox.

Office demand and office stocks

  • CNBC TV’s Diana Olick will report on the state of office demand in the U.S. on Thursday, with a special focus on New York City.
  • SL Green is up roughly 12% in a month, and it’s gained 20% in three months. The stock has dropped 11% since the July high.
  • Vornado is up 16.6% in a month, and it’s added 24% in three months. The stock is 7% from the December high.
  • CBRE is up 22% in a month, but the stock has dropped 7% from the July 31st high.
  • BXP is up 12% in a month, and it’s higher by 11% in three months. The stock is 8.7% from the December high.

Eli Lilly

  • The pharma giant will report quarterly numbers on Thursday morning.
  • Eli Lilly is up 32.5% so far in 2024.
  • The stock is 20% from the July high.
  • Eli Lilly is flat since over the past three months.

Retail earnings

  • Under Armour reports before the bell.
  • Capri Holdings reports after the bell. Their brands include Versace, Jimmy Choo and Michael Kors.
  • Class C shares of Under Armour are down 4.4% over the past three months. The stock is 30% from the December high.
  • Capri is down 13.7% in three months, and it’s 41.5% from the high hit almost a year ago.
Stock Chart IconStock chart icon

Capri Holdings, 3-month performance

Other retailers

  • Etsy hit a four-year low on Wednesday. The stock is 40% from the December high. The stock is down 18% in a week.
  • Ulta Beauty hit a 37-month low Wednesday. This stock is 44% from the March high, and it’s down 12% in a week.
  • Dollar Tree hit a 34-month low on Wednesday. The stock is down about 37% in a year, and it’s off by 22% in three months.
Stock Chart IconStock chart icon

Dollar Tree, one-year performance

Articles You May Like

Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
Charles Schwab CEO Walt Bettinger to retire at end of 2024, Rick Wurster to replace him
China stocks just had their best day in 16 years, sending related U.S. ETFs soaring
The One Way to Get in on Elon Musk’s Robotaxi Before Its 10/10 Debut
Strong Jobs Report Sets the Stage for a Holiday Stock Rally